Indermil" is a new formulation of n-Butyl-2-Cyanoacrylate used for securing skin grafts and surface wound closure. We report a prospective randomized trial, comparing the use of "Indermil" adhesive with suture in wound closure. A total of 30 patients underwent 37 procedures for the removal of benign skin lesions under local anaesthesia. "Indermil" was used in the skin closure in 18 procedures and sutures were used in 19 procedures. Scar quality, patient satisfaction and complications were recorded at a period between 8 and 18 months (median 12.2) following the procedure. The study showed no difference between the two groups in terms of scar quality and patient satisfaction. We conclude that long term outcome of wounds closed with "Indermil" are no different from sutured wounds.